Skip to content
value.today
Inogen, Inc. logo

Inogen, Inc.

INGN
$173 Mmarket cap on Oct 22, 2026+41.0% since Jan 2024
Compare
World rank
#16,778
Revenue
$349 M
For year ending December-2025
Net income
$-23 M
-6.5% margin
SEC filing
Employees
1,021
As on 2021
value.today research

Inogen, Inc. in brief

Inogen, Inc. is a listed company in the Medical Devices industry, based in California, USA. Its market value was $173 M on 22 October 2026, which makes it the 16,778th largest listed company in the world and the 3,239th largest in the USA on this site. In the year to December 2025 it had sales of $349 M and a net loss of $23 M. It employs about 1,021 people. By market, the largest shares of its 2025 sales came from USA (60%). Its shares trade under the symbol INGN (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Inogen, Inc.

Inogen provides Portable Oxygen Concentrators that are designed to offer a self replenishing, unlimited supply of oxygen that is concentrated from the surrounding air and to operate without the need for oxygen tanks or regular oxygen deliveries. It is operating in 46 countries. The headquarters is in USA.

Inogen, Inc. timeline

4 events, 2004–2023
  1. 2004
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2014
  4. 🔔
    Initial public offering on Nasdaq
    Final prospectus filed with the SEC on 14 February 2014; shares registered for exchange trading on 10 February 2014.
  5. 2022
  6. 💰
    Record revenue of $377 million
    FY2022, the highest of the 8 years on record.
  7. 2023
  8. 💰
    Record net income of $102 million
    FY2023, the highest profit of the 7 years on record.

Events of Inogen, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$397 M$793 M$1.2 B$1.6 B2020202120222023202420252026

World rank over time

▼ down 10,679 places since 2020
2020-01-01: #6145#6,14520202021-01-01: #7991#7,99120212022-01-07: #11106#11,10620222022-12-25: #13002#13,00220222023-07-30: #18401#18,40120232024-01-05: #20361#20,36120242026-03-08: #9169#9,16920262026-08-01: #16158#16,15820262026-10-07: #17340#17,34020262026-10-22: #16824#16,8242026

Rank in USA: #1,780 (Jan 2020) · #2,229 (Jan 2021) · #2,839 (Jan 2022) · #2,695 (Dec 2022) · #3,664 (Jul 2023) · #3,557 (Jan 2024) · #1,753 (Mar 2026) · #3,230 (Aug 2026) · #3,280 (Oct 2026) · #3,243 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
0.5×
Price / book
0.9×
Free cash flow yield
-7.9%
Net margin (TTM)
-10.1%
Operating margin
-8.7%
Return on equity
-18.5%
Liabilities / assets
35.6%
Net debt
$-57M
Revenue growth
+3.9%
R&D / revenue
5.6%
Revenue per employee
$341 K
Profit per employee
$-22 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue $358M, net income $52M$358MFY18Fiscal year ending Dec 2019: revenue $362M, net income $21M$362MFY19Fiscal year ending Dec 2020: revenue $308M, net income $-6M$308MFY20Fiscal year ending Dec 2021: revenue $358M, net income $-6M$358MFY21Fiscal year ending Dec 2022: revenue $377M, net income $-84M$377MFY22Fiscal year ending Dec 2023: revenue $316M, net income $-102M$316MFY23Fiscal year ending Dec 2024: revenue $336M, net income $-36M$336MFY24Fiscal year ending Dec 2025: revenue $349M, net income $-23M$349MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$349M+3.9%$-30M$-23M-6.5%
Dec 2024$336M+6.3%$-43M$-36M-10.7%
Dec 2023$316M-16.3%$-109M$-102M-32.5%
Dec 2022$377M+5.4%$-85M$-84M-22.2%
Dec 2021$358M+16.0%$9M$-6M-1.8%
Dec 2020$308M-14.8%$-12M$-6M-1.9%
Dec 2019$362M+1.1%$20M$21M5.8%
Dec 2018$358M—$38M$52M14.5%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-11M$3M$-14M$-0.86—
Dec 2024$6M$3M$3M$-1.52—
Dec 2023$-3M$5M$-8M$-4.42—
Dec 2022$-38M$3M$-41M$-3.67—
Dec 2021$24M$5M$18M$-0.28—
Dec 2020$37M$4M$33M$-0.27—
Dec 2019$41M$3M$37M$0.94—
Dec 2018$60M$8M$52M$2.30—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$352M
Net income, trailing 12 months
$-35M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $80M, net income $-10M$80MDec ’24Three months to Mar 2025: revenue $82M, net income $-6M$82MMar ’25Three months to Jun 2025: revenue $92M, net income $-4M$92MJun ’25Three months to Sep 2025: revenue $79M, net income $-5M$79MSep ’25Three months to Dec 2025 (from the annual report): revenue $95M, net income $-7M$95MDec ’25Three months to Mar 2026: revenue $85M, net income $-8M$85MMar ’26Three months to Jun 2026: revenue $95M, net income $-4M$95MJun ’26Three months to Sep 2026: revenue $77M, net income $-16M$77MSep ’26

Latest quarter to Sep 2026: revenue $77M (-2.4% on a year earlier), net income $-16M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Inogen, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$349 M
Operating income
$-30 M
Net income
$-23 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$299 M
Total liabilities
$106 M
Total equity
$192 M

As of December-2025

Top 100 institutional investors in Inogen, Inc.#

As of Sep 30, 2026
138 institutions held 18.3 M shares (about 70.3% of the shares outstanding) on Sep 30, 2026. The ten largest hold 36.0%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Inogen, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1BlackRock, Inc.1,744,782-4,204 (-0.24%)6.71%$9 MNov 13, 2026
2Armistice Capital, LLC1,236,000+140,000 (+12.77%)4.75%$7 MNov 16, 2026
3Acadian Asset Management LLC1,096,8790 (0.00%)4.22%$6 MNov 9, 2026
4Vanguard Capital Management LLC1,038,3160 (0.00%)3.99%$5 MNov 13, 2026
5DAFNA Capital Management LLC845,1790 (0.00%)3.25%$4 MNov 16, 2026
6Arrowstreet Capital, Limited Partnership778,083+34,831 (+4.69%)2.99%$4 MNov 13, 2026
7Morgan Stanley691,591+45,315 (+7.01%)2.66%$4 MNov 13, 2026
8Jpmorgan Chase & Co679,870+199,562 (+41.55%)2.61%$4 MNov 12, 2026
9AQR Capital Management LLC654,635-282,699 (-30.16%)2.52%$3 MNov 16, 2026
10State Street Corp591,584-359 (-0.06%)2.28%$3 MNov 12, 2026
11Federated Hermes, Inc.566,035+31,099 (+5.81%)2.18%$3 MNov 12, 2026
12Goldman Sachs Group Inc558,309+122,724 (+28.17%)2.15%$3 MNov 16, 2026
13Geode Capital Management, LLC534,536-106,985 (-16.68%)2.06%$3 MNov 6, 2026
14Renaissance Technologies LLC479,000+2,300 (+0.48%)1.84%$3 MNov 12, 2026
15Dimensional Fund Advisors LP455,886-32,759 (-6.70%)1.75%$2 MNov 4, 2026
16CSM Advisors, LLC379,500-33,925 (-8.21%)1.46%$2 MNov 13, 2026
17Citadel Advisors LLC323,009New1.24%$2 MNov 16, 2026
18Jacobs Levy Equity Management, Inc322,163-66,625 (-17.14%)1.24%$2 MNov 16, 2026
19Peapod Lane Capital LLC268,144+5,369 (+2.04%)1.03%$1 MOct 22, 2026
20Vanguard Portfolio Management LLC256,907+4,151 (+1.64%)0.99%$1 MNov 13, 2026
21Readystate Asset Management LP246,110-20,224 (-7.59%)0.95%$1 MNov 16, 2026
22Point72 Asset Management, L.P.227,336+55,994 (+32.68%)0.87%$1 MNov 16, 2026
23Moore Capital Management, LP225,233-63,895 (-22.10%)0.87%$1 MNov 16, 2026
24Steward Partners Investment Advisory, LLC205,181+3,650 (+1.81%)0.79%$1 MNov 13, 2026
25Quantinno Capital Management LP202,882+70,155 (+52.86%)0.78%$1 MNov 13, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Inogen, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Bridgeway Capital Management, LLC194,429-622 (-0.32%)0.75%$1 MNov 16, 2026
27Northern Trust Corp192,469-4,777 (-2.42%)0.74%$1 MNov 16, 2026
28UBS Group AG191,516-110,080 (-36.50%)0.74%$1 MNov 10, 2026
29Vanguard Fiduciary Trust Co169,470+5,712 (+3.49%)0.65%$1 MNov 13, 2026
30Prudential Financial Inc167,170-161,800 (-49.18%)0.64%$1 MNov 16, 2026
31Nuveen, LLC163,573-21,999 (-11.85%)0.63%$1 MNov 10, 2026
32Marshall Wace, LLP160,815New0.62%$1 MNov 13, 2026
33Monaco Asset Management SAM135,742-25,000 (-15.55%)0.52%$1 MNov 9, 2026
34Russell Investments Group, Ltd.133,294+101,214 (+315.50%)0.51%$1 MNov 6, 2026
35Bank of New York Mellon Corp117,989-401 (-0.34%)0.45%$1 MNov 5, 2026
36D. E. Shaw & Co., Inc.117,899+80,728 (+217.18%)0.45%$1 MNov 16, 2026
37Credit Agricole S A112,0000 (0.00%)0.43%$1 MNov 13, 2026
38Ameriprise Financial Inc108,987-874,041 (-88.91%)0.42%$1 MNov 16, 2026
39Tocqueville Asset Management L.P.93,3500 (0.00%)0.36%$0 MNov 13, 2026
40Charles Schwab Investment Management Inc81,369+7,204 (+9.71%)0.31%$0 MNov 16, 2026
41Connor, Clark & Lunn Investment Management Ltd.71,016+29,431 (+70.77%)0.27%$0 MNov 10, 2026
42Invesco Ltd.66,728+5,340 (+8.70%)0.26%$0 MNov 12, 2026
43American Century Companies Inc60,356-479 (-0.79%)0.23%$0 MNov 12, 2026
44Mackenzie Financial Corp58,697-152,163 (-72.16%)0.23%$0 MNov 2, 2026
45Alliancebernstein L.P.57,9200 (0.00%)0.22%$0 MNov 16, 2026
46Panagora Asset Management Inc53,714+1,291 (+2.46%)0.21%$0 MNov 12, 2026
47BNP Paribas Financial Markets51,610-12,834 (-19.91%)0.20%$0 MNov 12, 2026
48Barclays PLC48,334+5,727 (+13.44%)0.19%$0 MNov 6, 2026
49Campbell & CO Investment Adviser LLC47,893-15,923 (-24.95%)0.18%$0 MNov 13, 2026
50XTX Topco Ltd45,696+2,320 (+5.35%)0.18%$0 MNov 16, 2026
51Assenagon Asset Management S.A.44,185-129,695 (-74.59%)0.17%$0 MOct 15, 2026
52Mercer Global Advisors Inc /adv42,571+11,634 (+37.61%)0.16%$0 MNov 16, 2026
53Price T Rowe Associates Inc /MD/41,669+3,526 (+9.24%)0.16%$0 MNov 16, 2026
54Bank Of America Corp /de/38,706+5,823 (+17.71%)0.15%$0 MNov 16, 2026
55Ieq Capital, LLC38,407-35,182 (-47.81%)0.15%$0 MNov 10, 2026
56Polar Asset Management Partners Inc.37,995New0.15%$0 MNov 16, 2026
57Corient Private Wealth LP37,745New0.15%$0 MNov 16, 2026
58Empowered Funds, LLC36,078New0.14%$0 MNov 13, 2026
59FMR LLC35,530+18,147 (+104.40%)0.14%$0 MNov 10, 2026
60Millennium Management LLC30,424+6,856 (+29.09%)0.12%$0 MNov 16, 2026
61Prelude Capital Management, LLC30,386+15,728 (+107.30%)0.12%$0 MNov 16, 2026
62Rhumbline Advisers29,349-257 (-0.87%)0.11%$0 MNov 10, 2026
63Susquehanna International Group, LLP28,915+18,514 (+178.00%)0.11%$0 MNov 16, 2026
64Tidal Investments LLC27,657+1,683 (+6.48%)0.11%$0 MNov 13, 2026
65Occudo Quantitative Strategies LP26,528New0.10%$0 MNov 16, 2026
66HSBC Holdings PLC25,957-17,849 (-40.75%)0.10%$0 MNov 16, 2026
67HRT Financial LP25,316New0.10%$0 MNov 13, 2026
68Cerity Partners LLC22,860-8,693 (-27.55%)0.09%$0 MNov 13, 2026
69Deutsche Bank AG\21,104-3,049 (-12.62%)0.08%$0 MNov 6, 2026
70AlphaCore Capital LLC20,974+99 (+0.47%)0.08%$0 MNov 4, 2026
71Savant Capital, LLC20,514New0.08%$0 MNov 6, 2026
72Jane Street Group, LLC18,844+2,668 (+16.49%)0.07%$0 MNov 12, 2026
73Divisadero Street Capital Management, LP18,4130 (0.00%)0.07%$0 MNov 16, 2026
74Two Sigma Investments, LP18,180+3,165 (+21.08%)0.07%$0 MNov 16, 2026
75Engineers Gate Manager LP17,900New0.07%$0 MNov 16, 2026
76Aigen Investment Management, LP17,196+6,855 (+66.29%)0.07%$0 MNov 16, 2026
77Quadrature Capital Ltd17,188+7,038 (+69.34%)0.07%$0 MNov 13, 2026
78Integrated Wealth Concepts LLC16,873+145 (+0.87%)0.06%$0 MNov 17, 2026
79Wealth Enhancement Advisory Services, LLC15,954-7,407 (-31.71%)0.06%$0 MOct 13, 2026
80Mariner, LLC14,975-15,121 (-50.24%)0.06%$0 MNov 12, 2026
81Bank Of Montreal /can/14,905New0.06%$0 MNov 9, 2026
82Royce & Associates LP14,529New0.06%$0 MNov 9, 2026
83MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.12,002+603 (+5.29%)0.05%$0 MNov 16, 2026
84Arax Advisory Partners10,683-1,022 (-8.73%)0.04%$0 MNov 12, 2026
85Vanguard Personalized Indexing Management, LLC10,334New0.04%$0 MNov 16, 2026
86Vanguard Global Advisers, LLC8,195+90 (+1.11%)0.03%$0 MNov 13, 2026
87New York State Common Retirement Fund7,3970 (0.00%)0.03%$0 MNov 17, 2026
88Police & Firemen's Retirement System of New Jersey7,0430 (0.00%)0.03%$0 MNov 9, 2026
89PNC Financial Services Group, Inc.6,689+5,125 (+327.69%)0.03%$0 MNov 6, 2026
90Tower Research Capital LLC (TRC)5,867+3,842 (+189.73%)0.02%$0 MNov 16, 2026
91Wells Fargo & Company/mn4,813-15,918 (-76.78%)0.02%$0 MNov 16, 2026
92Employees Retirement System of Texas4,008New0.02%$0 MNov 10, 2026
93Walleye Capital LLC3,968New0.02%$0 MNov 13, 2026
94Nisa Investment Advisors, LLC3,579-2,558 (-41.68%)0.01%$0 MOct 20, 2026
95Pinnacle Wealth Planning Services, Inc.3,534+1,317 (+59.40%)0.01%$0 MOct 27, 2026
96UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC2,283+2,172 (+1956.76%)0.01%$0 MNov 16, 2026
97Versant Capital Management, Inc2,204-1,776 (-44.62%)0.01%$0 MOct 2, 2026
98Legal & General Group Plc2,1340 (0.00%)0.01%$0 MNov 16, 2026
99GAMMA Investing LLC1,678+920 (+121.37%)0.01%$0 MOct 8, 2026
100Ameritas Investment Partners, Inc.1,5980 (0.00%)0.01%$0 MNov 13, 2026

All 138 institutional investors, with who bought and sold →

Mutual funds holding Inogen, Inc.#

133 funds hold shares worth $37 M (about 22.3% of the company). Since their previous reports 42 added shares and 28 sold, buying $0 M net.
Mutual funds holding Inogen, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.739,966$5 M2.8%<0.01%no changeJun 30, 2026
🇺🇸 Columbia Small Cap Value Discovery FundColumbia Management Investment Advisers, LLC644,211$4 M2.5%0.17%+6.5%Jul 31, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors643,736$4 M2.5%<0.01%+11%Jun 30, 2026
🇺🇸 Federated Hermes MDT Small Cap Core FundFederated Hermes MDT Series371,379$2 M1.4%0.11%no changeJul 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.271,196$2 M1.0%<0.01%+2.4%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC267,300$2 M1.0%<0.01%+14%Jul 31, 2026
🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors219,250$1 M0.84%<0.01%+9.1%Jun 30, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC133,234$1 M0.51%<0.01%−57%Jun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC130,575$1 M0.50%<0.01%+3.6%May 31, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.122,742$1 M0.47%<0.01%+4.6%May 31, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP120,640$1 M0.46%<0.01%no changeJul 31, 2026
🇺🇸 Columbia Variable Portfolio - Small Cap Value Discovery FundColumbia Management Investment Advisers, LLC116,530$1 M0.45%0.17%−3.4%Jun 30, 2026
🇺🇸 JPMorgan U.S. Small Company FundJ.P. Morgan Investment Management Inc.94,635$1 M0.36%0.05%−6.7%Jun 30, 2026
🇺🇸 Vanguard Strategic Small-Cap Equity FundThe Vanguard Group, Inc.88,572$1 M0.34%0.02%no changeJun 30, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP84,571$1 M0.33%<0.01%no changeJul 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors82,873$1 M0.32%0.04%+40%Jun 30, 2026
🇺🇸 Goldman Sachs Small Cap Value Insights FundGoldman Sachs Asset Management, L.P.82,529$1 M0.32%0.04%−48%Jul 31, 2026
🇺🇸 JPMorgan Small Cap Value FundJ.P. Morgan Investment Management Inc.81,693$1 M0.31%0.04%newJun 30, 2026
🇺🇸 AST PGIM Aggressive Multi-Asset PortfolioAST Investment Services, Inc.73,600$0 M0.28%<0.01%−23%Jun 30, 2026
🇺🇸 Federated Hermes MDT Small Cap Core ETFFederated Advisory Services Company68,219$0 M0.26%0.16%+73%May 31, 2026
🇺🇸 Multi-Manager Small Cap Equity Strategies FundColumbia Funds Series Trust I66,808$0 M0.26%0.03%+43%May 31, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP58,994$0 M0.23%<0.01%−35%Jul 31, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.57,562$0 M0.22%<0.01%+12%Jul 31, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC49,112$0 M0.19%0.03%+688%Jul 31, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust48,644$0 M0.19%0.01%no changeMay 31, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC47,819$0 M0.18%<0.01%no changeMay 31, 2026
🇺🇸 NVIT Multi-Manager Small Company FundNATIONWIDE FUND ADVISORS47,221$0 M0.18%0.07%no changeJun 30, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP41,509$0 M0.16%<0.01%no changeJul 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC41,210$0 M0.16%<0.01%no changeJun 30, 2026
🇺🇸 NVIT Small Cap Value FundNATIONWIDE FUND ADVISORS39,730$0 M0.15%0.12%no changeJun 30, 2026
🇺🇸 Small Cap Equity FundGuideStone Capital Management, LLC38,419$0 M0.15%0.02%+6.8%Jun 30, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC37,544$0 M0.14%<0.01%no changeMay 31, 2026
🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC36,700$0 M0.14%0.16%no changeJun 30, 2026
🇺🇸 Federated Hermes MDT Small Cap Value Fund f/k/a Federated Hermes Clover Small Value FundFederated Hermes Equity Funds36,114$0 M0.14%0.13%no changeJun 30, 2026
🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC34,352$0 M0.13%0.01%+17%Jun 30, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC32,057$0 M0.12%<0.01%no changeJul 31, 2026
🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC32,045$0 M0.12%<0.01%−9.3%Jul 31, 2026
🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP28,702$0 M0.11%<0.01%newJul 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC28,312$0 M0.11%<0.01%no changeJun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.27,333$0 M0.11%<0.01%+76%Jun 30, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC26,640$0 M0.10%<0.01%+15%Jun 30, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC23,720$0 M0.09%<0.01%+17%Jun 30, 2026
🇺🇸 LVIP JPMorgan Small Cap Core FundLincoln Financial Investments Corporation21,118$0 M0.08%0.06%−5.4%Jun 30, 2026
🇺🇸 JPMorgan Small Cap Value PortfolioBrighthouse Investment Advisers, LLC20,568$0 M0.08%0.04%newJun 30, 2026
🇺🇸 T. Rowe Price Extended Equity Market Index FundT. Rowe Price Associates, Inc.20,000$0 M0.08%0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc.18,133$0 M0.07%<0.01%+4.7%May 31, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.16,555$0 M0.06%<0.01%no changeJul 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation14,790$0 M0.06%<0.01%−20%Jun 30, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC14,132$0 M0.05%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.13,936$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 Vy Jpmorgan Small Cap Core Equity PortfolioVoya Investments, LLC13,901$0 M0.05%0.03%−5.0%Jun 30, 2026
🇺🇸 AQR Small Cap Multi-Style FundAQR CAPITAL MANAGEMENT, LLC13,324$0 M0.05%0.02%newJun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.13,218$0 M0.05%<0.01%−26%Jun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.12,467$0 M0.05%<0.01%−4.1%Jun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC12,246$0 M0.05%<0.01%−49%May 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC11,869$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC11,822$0 M0.05%<0.01%+13%Jul 31, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC11,633$0 M0.04%<0.01%no changeJul 31, 2026
🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC10,056$0 M0.04%<0.01%newJun 30, 2026
🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP10,041$0 M0.04%<0.01%no changeJul 31, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC9,219$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company8,576$0 M0.03%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC8,643$0 M0.03%<0.01%+2.6%Jul 31, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC8,497$0 M0.03%<0.01%+1360%Jun 30, 2026
🇺🇸 PGIM Balanced FundPrudential Investment Portfolios, Inc.8,400$0 M0.03%<0.01%−18%Jun 30, 2026
🇺🇸 Avantis Total Equity Markets ETFAmerican Century ETF Trust7,360$0 M0.03%<0.01%no changeMay 31, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.7,292$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC6,801$0 M0.03%<0.01%+39%Jun 30, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC6,640$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.5,741$0 M0.02%0.02%−81%Jun 30, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC5,687$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC5,637$0 M0.02%0.02%+34%Jun 30, 2026
🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc.4,940$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP4,900$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors4,690$0 M0.02%<0.01%−0.7%Jun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS4,635$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 SA Multi-Managed Small Cap PortfolioSunAmerica Asset Management, LLC4,462$0 M0.02%0.02%−9.1%Jun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION4,100$0 M0.02%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC4,039$0 M0.02%<0.01%+11%Jul 31, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC4,014$0 M0.02%<0.01%+38%Jun 30, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.3,941$0 M0.02%<0.01%+24%Jun 30, 2026
🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC3,896$0 M0.01%<0.01%−0.2%Jun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.3,731$0 M0.01%<0.01%+57%Jun 30, 2026
🇺🇸 EQ/Common Stock Index PortfolioEquitable Investment Management Group, LLC3,600$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC3,522$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Dimensional US Core Equity Market ETFDimensional Fund Advisors LP3,394$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Invesco Russell 2000 Dynamic Multifactor ETFInvesco Capital Management LLC3,333$0 M0.01%<0.01%+18%May 31, 2026
🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP3,200$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP3,192$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.3,040$0 M0.01%<0.01%+11%Jul 31, 2026
🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP3,001$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Dimensional US Vector Equity ETFDimensional Fund Advisors LP2,852$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Avantis U.S. Equity ETFAmerican Century ETF Trust2,676$0 M0.01%<0.01%no changeMay 31, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC2,678$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC2,564$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC2,240$0 M<0.01%<0.01%+45%Jun 30, 2026
🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC2,200$0 M<0.01%<0.01%+22%May 31, 2026
🇺🇸 Avantis U.S. Small Cap Equity FundAmerican Century ETF Trust2,116$0 M<0.01%0.01%no changeMay 31, 2026
🇺🇸 SmallCap Value Fund IIPrincipal Global Investors, LLC2,029$0 M<0.01%<0.01%+131%Jul 31, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC1,970$0 M<0.01%<0.01%no changeJun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Inogen, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$143 K
2 sales, 1 insider
Net, 12 months
-$143 K
open market only
Insiders on file
53
since
$125 K-$86 K$0May 2024: bought $0 (0 trades), sold $86 K (1 trades)May 24Mar 2025: bought $125 K (2 trades), sold $0 (0 trades)MarMay 2026: bought $0 (0 trades), sold $70 K (1 trades)MayJul 2026: bought $0 (0 trades), sold $72 K (1 trades)Jul
Bought (open market)Sold (open market)Hover a month for the totals
Inogen, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Smith Kevin Raymond MerrillCEO and President, DirectorGrant or award10b5-1 plan+1,500$5.330$8 K134,962Form 4
filed Mary E. WrightVP, Chief Accounting OfficerGrant or award+1,500$5.330$8 K20,629Form 4
filed Kevin P. SmithEVP, Bus Dev, GC & SecGrant or award10b5-1 plan+1,500$5.330$8 K23,507Form 4
filed Kevin P. SmithEVP, Bus Dev, GC & SecOption exercise10b5-1 plan+18,136——41,643Form 4
filed Kevin P. SmithEVP, Bus Dev, GC & SecShares withheld for tax10b5-1 plan-8,671$5.330$46 K32,972Form 4
filed Boyer Jennifer M. YiEVP Entrprs Enblmnt, Ch HR OffSell10b5-1 plan-10,938$6.600$72 K5,039Form 4
filed Kevin M. KingDirectorGrant or award+28,081——104,966Form 4
filed Mira Kirti SahneyDirectorGrant or award+28,081——67,805Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Inogen, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
1.4 M
5.2% of shares · 5.76 days to cover
Buybacks, Q3 2026
$3.7M
Q3 2026
Shares sold short, last 24 reportsAll stocks →
Inogen, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q3 2026Q3 2026$3.7M
Q2 2026Q2 2026$5.6M
Q1 2026Q1 2026$1.9M

Trading halts

  • 2026-11-06 14:32 UTC, code LUDP, resumed 14:37 UTC

Fails to deliver

  • : 99 shares at $6.67
  • : 734 shares at $5.77
  • : 278 shares at $5.27
  • : 15,156 shares at $5.56
  • : 20 shares at $5.50

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Inogen, Inc. scorecard#

Passes 6 of the 20 checks that could be worked out: strongest in valuation (2 of 5), weakest in profitability (1 of 5). Fiscal year 2025; market cap of Oct 22, 2026.

  • Valuation2 of 5
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✓Price to book below its peers' median0.9×Price to book 0.9× against Medical Devices's median of 2.5×.
    • ✓Price to sales below its peers' median0.5×Price to sales 0.5× against Medical Devices's median of 2.4×.
    • ✗Free cash flow yield above 5%-7.9%Free cash flow is -7.9% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth2 of 6
    • ✓Revenue grew in the newest year3.9%Revenue up 3.9% in fiscal 2025.
    • ✗Revenue up more than 5% a year over three years-2.6%-2.6% a year over the three years to fiscal 2025.
    • ✗Faster growth over three years than its peers' median-2.6%-2.6% a year against Medical Devices's median of 10.8% (73 companies).
    • ✗Earnings per share grew in the newest year-0.86 vs -1.52Diluted EPS -0.86 in fiscal 2025 against -1.52 the year before (report's currency).
    • ✗Net income higher than five years earlier-$23 M-$23 M in fiscal 2025 against -$6 M in 2020.
    • ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
  • Profitability1 of 5
    • ✗Profitable in the newest year-$23 MNet income -$23 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-8.7%-8.7% against Medical Devices's median of -8.2% (86 companies).
    • ✗Return on equity above 15%-12.4%-12.4% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier-8.7%-8.7% in fiscal 2025 against -22.6% in 2022.
  • Financial health1 of 3
    • ✓Short-term assets cover short-term liabilities3.5×Current ratio 3.53 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2025.
    • ✗Altman Z-score outside the distress zone1.64Z-score 1.64 (distress zone) for fiscal 2025.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year12.5%Diluted shares up 12.5% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Inogen, Inc.'s statements, beside the median of Medical Devices.

Inogen, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-8.7%-8.2%
Net margin-6.5%-10.4%
Return on equity-12.4%-16.8%
Revenue growth, 3 years a year-2.6%10.8%
Revenue growth3.9%10.4%
Free cash flow margin-3.9%-1.9%

4of 8on the Piotroski tests of financial strength

  • Net loss of $23 million, the 6th loss-making year in a row.
  • Free cash flow was negative: -$14 million.
  • The share count rose 12.5% in the year.

Inogen, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Inogen, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue349336316377358308362358249203
Cost of revenue194181189224182170190180128106
Gross profit15415512715417613817217912197
Research and development1922212217149.47.05.35.1
Selling and marketing9810310712111398106965138
General and administrative67737544383937383832
Operating expenses1841972362391671501521419474
Operating income−30−43−109−859.2−1220382823
Interest and finance income4.45.26.62.80.10.94.73.30.80.2
Interest expense and finance costs—————————0.0
Other non-operating income (expense)6.86.07.02.0−0.66.74.52.62.1−0.1
Income before tax−23−36−102−838.7−5.324403023
Income tax−0.6−0.60.10.5150.53.3−118.72.2
Net income attributable to shareholders−23−36−102−84−6.3−5.821522121
Earnings per share, basic-0.86-1.52-4.42-3.67-0.28-0.270.962.441.021.02
Earnings per share, diluted-0.86-1.52-4.42-3.67-0.28-0.270.942.300.960.97
Shares, weighted average (basic)27242323222222212120
Shares, weighted average (diluted)27242323222222232221
Balance sheet
Cash and cash equivalents10411412518723621219819714393
Short-term investments1603.0—10.01911443121
Receivables34r304263243034373131
Inventory26252234322536271914
Other current assets11r14r14192618107.5r2.61.7
Current assets225r185207305329306292315228162
Property, plant and equipment10r445043392819222025
Right-of-use (leased) assets17182022258.85.9———
Goodwill119.510333333332.32.4—
Other intangible assets3130350.26069783.84.70.2
Total assets299296326405490462447376275214
Accounts payable20r171318101316149.55.7
Current liabilities64777265625750473423
Lease liabilities (non-current)14171820238.14.7———
Total liabilities106122121108119112103654832
Retained earnings−176−153−117−15697681608.6−12
Shareholders' equity192174205297370350345310227182
Total liabilities and equity299296326405490462447376275214
Shares outstanding27242323232222222120
Cash-flow statement
Depreciation and amortization21211824221914111214
Share-based compensation8.07.47.412118.29.1139.67.3
Cash from operating activities−115.9−3.2−38243741606031
Capital expenditure−2.5−3.4−5.2−3.3−5.5−4.4−3.1−8.0−2.9−1.7
Intangible assets bought—−2.1−0.5—−0.1−0.3−0.3−0.4−3.3−0.1
Acquisitions, net of cash acquired——−30———−70—−4.5—
Cash from investing activities−26−14−59−11−15−26−44−25−24−12
Debt repaid—————————−0.3
Shares issued27—————————
Cash from financing activities240.31.00.4152.14.918147.7
Change in cash−12−8.1−62−4924141.4545027
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Inogen, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Countries and regions

  • 🇺🇸 USA$210 M60%
  • International revenue(total)$139 M40%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Where Inogen, Inc. operates: 4 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 3 subsidiaries on file.

Inogen, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters1 office$210 M60%
🇫🇷 France1 subsidiary—
🇩🇪 Germany1 subsidiary—
🇳🇱 Netherlands1 subsidiary—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at Inogen, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$3.0 M
Kevin R.M. Smith
Other top executives, average
$1.5 M
the CEO earned 2× this
$100 invested is now
$15
peer group: $78
Inogen, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Kevin R.M. Smith$3.0 M$1.9 M$1.5 M$15 (peers $78)
2024Kevin R.M. Smith$4.2 M$5.4 M$961 K$21 (peers $78)
2023Nabil Shabshab, Kevin R.M. Smith$4.3 M−$1.4 M$1.1 M$12 (peers $74)
2022Nabil Shabshab$6.3 M$3.2 M$2.0 M$44 (peers $79)
2021Nabil Shabshab, Scott Wilkinson$7.0 M$5.6 M$1.2 M$76 (peers $103)

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at Inogen, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Acquisition or sale completed 1 · Directors and officers 12 · Material agreement 3 · Unregistered share sale 1 · Shareholder vote 3 · Results announced 13

Inogen, Inc.: events reported to the SEC
FiledWhat happenedFiling
Acquisition or sale completedDirectors and officersResults announced8-K
Material agreement8-K
Results announced8-K
Directors and officers8-K
Directors and officersShareholder vote8-K
Results announced8-K
Directors and officersMaterial agreement8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Directors and officersShareholder vote8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Material agreementUnregistered share sale8-K
Results announced8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Directors and officers8-K
Directors and officersShareholder vote8-K
Directors and officers8-K
Results announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 5, 2026

Acquisitions and funding#

1 acquisitions · 1 private funding rounds before listing

Businesses it acquired

Acquisitions by Inogen, Inc.
AcquiredAcquisition dateCompletionPriceStakeSource
Physio-Assist SASSep 2023Sep 2023——Annual report

Private share sales · funding history

Private share sales of Inogen, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2010$10 MNo. 1$2 to $10 million8equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Layoffs at Inogen, Inc.#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
0
2022–2022
Latest
—
2022-12-19
Inogen, Inc.: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2022············—
Inogen, Inc.: latest layoffs
AnnouncedPeopleKindWhereSource
Not statedRestructuring planSEC 8-KCompany-wide planFiling

Source: State WARN notices and SEC 8-K item 2.05

How Inogen, Inc. compares in Medical Devices

  • Market cap$173 M · higher than 40% of 142
  • Revenue$349 M · higher than 64% of 155
  • Net margin-10.1% · higher than 47% of 144
  • Revenue growth3.9% · higher than 28% of 104
  • Price / sales0.5× · lower than 95% of 96
  • Price / book0.9× · lower than 87% of 99
  • FCF yield-7.9% · higher than 33% of 76

Peer comparison · Medical Devices

CompanyMarket capP/ENet marginRev. growth
Inogen, Inc.🇺🇸$173 M—-10.1%+3.9%
Abbott Laboratories🇺🇸$181.1 B38.5×9.8%+5.7%
Medtronic plc🇺🇸$121.2 B23.2×13.9%+8.4%
Stryker Corporation🇺🇸$116.5 B32.2×13.8%+11.2%
Boston Scientific Corporation🇺🇸$66.2 B18.9×16.6%+19.9%
Edwards Lifesciences Corporation🇺🇸$52.8 B51.7×15.3%+11.6%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳$27.8 B23.6×24.4%—
STERIS plc🇮🇪$20.4 B24.6×13.4%+8.7%
Zimmer Biomet Holdings, Inc.🇺🇸$18.2 B23.8×8.9%+7.2%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 22, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As on 2021
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, GLEIF register; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Inogen, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Inogen, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Inogen, Inc.? Suggest a correction